ResMed has introduced the AirFit N20 nasal mask and AirFit F20 full face mask for positive airway pressure treatment of sleep apnea. The new-generation ResMed masks are the result of more than three years of research and development and include innovations designed to improve mask fit, comfort and ease of use.
The masks, which have yet to be approved by the FDA, were on display at Medtrade Fall in Atlanta on October 31st. Pending FDA approval, ResMed plans to make the AirFit F20 and AirFit N20 available in the US this quarter. Both masks are currently being rolled out in EMEA and Asia-Pacific.
The AirFit N20 and AirFit F20 feature ResMed’s new InfinitySeal silicone cushion that adapts to the unique facial contours of each patient to increase comfort, improve fit and reduce leakage for maximum treatment efficacy, the company announced in a press release.
Hard-to-fit masks affect sleep specialists and patients alike, so with the new AirFit 20 series, ResMed has taken one of its most popular mask features — magnetic clips, which make the headgear easier to get on and off — and introduced them on its full face model.
Testing shows the AirFit N20 fit 99% of patients tested, and the AirFit F20 fit 97% — regardless of facial structure, gender or age, according to studies cited by the company.
“These new masks address two of the biggest catalysts for effective sleep apnea treatment: fit and comfort,” said ResMed CEO Mick Farrell. “Patients rate mask comfort as the number one reason that can help them stay on therapy. Not only are the F20 and N20 our most comfortable masks ever, they’re easier and faster for clinicians to fit on patients the first time, helping more people suffering from sleep apnea adhere to this life-changing therapy.”
The masks are part of ResMed’s Air Solutions connected care portfolio, complementing its best-selling, cloud-enabled Air10 flow generator devices and myAir and AirView monitoring tools that are proven to help improve patients’ CPAP use.